These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 26276434)
1. Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors. Zhao C; Wang Y; Ma S Eur J Med Chem; 2015 Sep; 102():188-214. PubMed ID: 26276434 [TBL] [Abstract][Full Text] [Related]
2. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors. Mish MR; Cho A; Kirschberg T; Xu J; Zonte CS; Fenaux M; Park Y; Babusis D; Feng JY; Ray AS; Kim CU Bioorg Med Chem Lett; 2014 Jul; 24(14):3092-5. PubMed ID: 24907145 [TBL] [Abstract][Full Text] [Related]
4. 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase. Küçükgüzel I; Satılmış G; Gurukumar KR; Basu A; Tatar E; Nichols DB; Talele TT; Kaushik-Basu N Eur J Med Chem; 2013 Nov; 69():931-41. PubMed ID: 24161679 [TBL] [Abstract][Full Text] [Related]
5. Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors. Hendricks RT; Fell JB; Blake JF; Fischer JP; Robinson JE; Spencer SR; Stengel PJ; Bernacki AL; Leveque VJ; Le Pogam S; Rajyaguru S; Najera I; Josey JA; Harris JR; Swallow S Bioorg Med Chem Lett; 2009 Jul; 19(13):3637-41. PubMed ID: 19447623 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase. Di Francesco ME; Avolio S; Pompei M; Pesci S; Monteagudo E; Pucci V; Giuliano C; Fiore F; Rowley M; Summa V Bioorg Med Chem; 2012 Aug; 20(15):4801-11. PubMed ID: 22770556 [TBL] [Abstract][Full Text] [Related]
7. Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase. Manfroni G; Meschini F; Barreca ML; Leyssen P; Samuele A; Iraci N; Sabatini S; Massari S; Maga G; Neyts J; Cecchetti V Bioorg Med Chem; 2012 Jan; 20(2):866-76. PubMed ID: 22197397 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase. Pierra Rouvière C; Amador A; Badaroux E; Convard T; Da Costa D; Dukhan D; Griffe L; Griffon JF; LaColla M; Leroy F; Liuzzi M; Loi AG; McCarville J; Mascia V; Milhau J; Onidi L; Paparin JL; Rahali R; Sais E; Seifer M; Surleraux D; Standring D; Dousson C Bioorg Med Chem Lett; 2016 Sep; 26(18):4536-4541. PubMed ID: 27520942 [TBL] [Abstract][Full Text] [Related]
9. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives. Rawal RK; Katti SB; Kaushik-Basu N; Arora P; Pan Z Bioorg Med Chem Lett; 2008 Dec; 18(23):6110-4. PubMed ID: 18947995 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors. Das D; Hong J; Chen SH; Wang G; Beigelman L; Seiwert SD; Buckman BO Bioorg Med Chem; 2011 Aug; 19(16):4690-703. PubMed ID: 21798747 [TBL] [Abstract][Full Text] [Related]
11. The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2'-α-chloro-2'-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors. Alexandre FR; Badaroux E; Bilello JP; Bot S; Bouisset T; Brandt G; Cappelle S; Chapron C; Chaves D; Convard T; Counor C; Da Costa D; Dukhan D; Gay M; Gosselin G; Griffon JF; Gupta K; Hernandez-Santiago B; La Colla M; Lioure MP; Milhau J; Paparin JL; Peyronnet J; Parsy C; Pierra Rouvière C; Rahali H; Rahali R; Salanson A; Seifer M; Serra I; Standring D; Surleraux D; Dousson CB Bioorg Med Chem Lett; 2017 Sep; 27(18):4323-4330. PubMed ID: 28835346 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitors. Barnes-Seeman D; Boiselle C; Capacci-Daniel C; Chopra R; Hoffmaster K; Jones CT; Kato M; Lin K; Ma S; Pan G; Shu L; Wang J; Whiteman L; Xu M; Zheng R; Fu J Bioorg Med Chem Lett; 2014 Aug; 24(16):3979-85. PubMed ID: 24986660 [TBL] [Abstract][Full Text] [Related]
13. New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase. Meguellati A; Ahmed-Belkacem A; Nurisso A; Yi W; Brillet R; Berqouch N; Chavoutier L; Fortuné A; Pawlotsky JM; Boumendjel A; Peuchmaur M Eur J Med Chem; 2016 Jun; 115():217-29. PubMed ID: 27017550 [TBL] [Abstract][Full Text] [Related]
14. A novel hepatitis C virus NS5B polymerase assay of de novo initiated RNA synthesis directed from a heteropolymeric RNA template. Ferrari E; Huang HC Methods Mol Biol; 2013; 1030():81-92. PubMed ID: 23821261 [TBL] [Abstract][Full Text] [Related]
16. Discovery of Novel Thiophene-Based, Thumb Pocket 2 Allosteric Inhibitors of the Hepatitis C NS5B Polymerase with Improved Potency and Physicochemical Profiles. Court JJ; Poisson C; Ardzinski A; Bilimoria D; Chan L; Chandupatla K; Chauret N; Collier PN; Das SK; Denis F; Dorsch W; Iyer G; Lauffer D; L'Heureux L; Li P; Luisi BS; Mani N; Nanthakumar S; Nicolas O; Rao BG; Ronkin S; Selliah S; Shawgo RS; Tang Q; Waal ND; Yannopoulos CG; Green J J Med Chem; 2016 Jul; 59(13):6293-302. PubMed ID: 27366941 [TBL] [Abstract][Full Text] [Related]
17. Cyclic amide bioisosterism: strategic application to the design and synthesis of HCV NS5B polymerase inhibitors. Yang H; Hendricks RT; Arora N; Nitzan D; Yee C; Lucas MC; Yang Y; Fung A; Rajyaguru S; Harris SF; Leveque VJ; Hang JQ; Pogam SL; Reuter D; Tavares GA Bioorg Med Chem Lett; 2010 Aug; 20(15):4614-9. PubMed ID: 20584604 [TBL] [Abstract][Full Text] [Related]
18. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives. Beaulieu PL; Bös M; Bousquet Y; Fazal G; Gauthier J; Gillard J; Goulet S; LaPlante S; Poupart MA; Lefebvre S; McKercher G; Pellerin C; Austel V; Kukolj G Bioorg Med Chem Lett; 2004 Jan; 14(1):119-24. PubMed ID: 14684311 [TBL] [Abstract][Full Text] [Related]
19. Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates. Malancona S; Donghi M; Ferrara M; Martin Hernando JI; Pompei M; Pesci S; Ontoria JM; Koch U; Rowley M; Summa V Bioorg Med Chem; 2010 Apr; 18(8):2836-48. PubMed ID: 20363140 [TBL] [Abstract][Full Text] [Related]
20. Current perspective of HCV NS5B inhibitors: a review. Patil VM; Gupta SP; Samanta S; Masand N Curr Med Chem; 2011; 18(36):5564-97. PubMed ID: 22172066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]